School of Medicine


Showing 21-30 of 756 Results

  • Sharada Kalanidhi

    Sharada Kalanidhi

    Director of Data Science, Biochemistry - Genome Center

    Current Role at StanfordCurrent Research: Mathematical Medicine

    The essential challenge is not merely to solve a problem, but to discover the mathematical framework in which the problem can be understood — a perspective associated with the mathematician Alexander Grothendieck.

    We spent decades using sophisticated mathematics to understand financial markets. What happens when we bring that same mathematical direction—and deeper ideas from pure mathematics—to understanding human biology?

    This question captures the intellectual motivation behind Sharada's current work: developing the foundations of Mathematical Medicine, a proposed new discipline that draws on pure mathematics to address fundamental challenges in individualized diagnosis, personalized therapeutics, cancer treatments, and healthy longevity.

    The work begins with a central challenge in contemporary medicine. Advances in genomics, proteomics, metabolomics, and computational biology have generated unprecedented volumes of biomedical data. Yet translating these measurements into meaningful insights for individual patients remains difficult, particularly for those with rare, complex, or previously unexplained conditions.

    Conventional statistical and machine learning approaches have transformed biomedical research, but their reliance on population-level patterns can limit their usefulness when an individual patient's biology differs substantially from that of available reference cohorts. Clinically meaningful differences may be treated as statistical noise or outliers rather than investigated as potential clues to underlying disease mechanisms.

    After more than a decade of research and collaboration with biochemists at SGTC, Sharada became increasingly interested in whether the mathematical foundations used to interpret biomedical data were sufficient for the complexity of individualized medicine.

    Her central premise is that progress in personalized medicine may require not simply more data or larger computational models, but new mathematical ways of understanding biological systems.

    Rather than applying existing statistical approaches to biomedical problems, Mathematical Medicine explores whether ideas from pure mathematics can fundamentally change how biological questions are formulated, understood, and solved.

    The research is guided by the possibility that deeper mathematical understanding can reveal - and preserve- meaningful biological relationships even when data are limited, heterogeneous, or difficult to interpret using conventional approaches.

    This approach echoes a perspective expressed by the mathematician Mikhail Gromov: “This area does not yet exist. It will have to be invented.”

    It also reflects the empirical philosophy associated with the mathematician and quantitative investor Jim Simons: “We don't start with models. We start with data. We don't have any preconceived notions.” The aim is to allow biological observations to guide mathematical inquiry, rather than forcing them into existing computational frameworks.

    Sharada's research has contributed to investigations of complex and previously unexplained clinical conditions, including cases in which mathematical and multi-omic analyses helped identify potential diagnoses and therapeutic pathways. These investigations also motivate broader questions about how individual biological differences can inform our understanding of disease.

    The long-term vision is to establish Mathematical Medicine as a rigorous discipline connecting pure mathematics, molecular biology, and clinical medicine—advancing mathematics toward a foundation for understanding individual biology, preserving biological mechanisms and informing clinical decisions.

    Further information about Mathematical Medicine, its research vision, and opportunities for early philanthropic partnerships is available at:

    https://mathmed-2026.web.app/

  • Anusha Kalbasi, MD

    Anusha Kalbasi, MD

    Associate Professor of Radiation Oncology (Radiation Therapy)

    BioDr. Kalbasi is a physician-scientist at the Stanford Cancer Institute. In the clinic, Dr. Kalbasi is a radiation oncologist specializing in the treatment of patients with sarcoma and other solid tumors, with expertise in early phase clinical trials related to immunotherapy, cellular therapy, and radiation therapy.

    The Kalbasi laboratory studies cancer immunology, with a focus on understanding—and re-engineering—the molecular conversations that immune cells have with one another and with cancer cells, especially through cytokines. By mapping how these signals are sent, received, and interpreted within immune cells and cancer cells, the lab aims to design next-generation immunotherapies that deliver the right messages at the right time—making cancer-fighting cells more potent, more persistent, and more precise.

  • Agnieszka Kalinowski

    Agnieszka Kalinowski

    Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)

    BioI am a translational physician-scientist committed to understanding the pathophysiology of schizophrenia to identify disease-modifying therapeutic interventions. I examined the role of C4 protein activation in clinical samples from individuals with schizophrenia compared to controls, its relationship to C4 CNV and effect on blood brain barrier permeability using in vitro model systems. I contributed to identifying LINE-1 insertions in postmortem brain samples of individuals with schizophrenia and C4 copy number variation (CNV) in pediatric patients with neuropsychiatric symptoms. Since accumulating evidence points to the synapses as the locus of pathology in schizophrenia, I am focusing my current research effort to defining the underlying abnormality in synapses in schizophrenia using a combination of in vitro iPS based model systems and postmortem brain samples, and applying cutting-edge techniques like spatial transcriptomics and array tomography.

  • Nathan Kalinowski, D.M.D.

    Nathan Kalinowski, D.M.D.

    Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery

    BioDr. Nathan Kalinowski is a Hospital Dentist and Clinical Assistant Professor in Dental Medicine and Surgery. He performs medically necessary dental clearance and extractions for patients preparing for cardiac surgery, radiation therapy, or organ transplantation. He also performs surgical treatment of infection and trauma to the teeth and supporting alveolar bone including reconstruction using dental implants.

  • Mausam Kalita

    Mausam Kalita

    Physical Science Research Professional 2, Rad/Molecular Imaging Program at Stanford

    Current Role at StanfordSenior Research Scientist: a) cold chemical synthesis— Synthesis of the 12C and 19F- HPLC standards and precursors for 11C- and 18F- labeling
    b) Radiosynthesis— Introduction of 11C or 18F radioisotopes into small molecules to develop novel PET tracers, that can track activated myeloid cells in neurodegenerative disease, c) radiometal labeling— 64Cu and 89Zr labeling of monoclonal antibodies that target immune receptors, d) clinical translation— To follow FDA guidelines for translating preclinically validated tracers into humans in the cyclotron and radiochemistry facility (CRF) of the Stanford University